Document is current
Any future updates will be listed below
-
Authors
Denimal, Damien
Ponnaiah, Maharajah
Jeannin, Anne-Caroline
Phan, Franck
Hartemann, Agnès
Boussouar, Samia
Charpentier, Etienne
Redheuil, Alban
Foufelle, Fabienne
Bourron, Olivier
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02431234 at ClinicalTrials.govnct03920683 at ClinicalTrials.govDocuments that mention this clinical trial
Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy
https://doi.org/10.1186/s13098-019-0429-7
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
https://doi.org/10.1186/s12933-020-01122-4
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
https://doi.org/10.1186/s12933-024-02161-x
Documents that mention this clinical trial
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
https://doi.org/10.1186/s12933-024-02161-x
-
Funding
Funding for this research was provided by:
Dijon University Hospital
Eli Lilly and Company
Ministère des Affaires Sociales et de la Santé (PHRC code project: P111105; N° ID RCB: 2013‑A00896‑39)
- License Information
-
More Information
Article History
Received: 15 December 2023
Accepted: 8 February 2024
First Online: 13 February 2024
Declarations
:
: The study was approved by the local ethics committee (PARIS VI CPP) and registered in ClinicalTrials.gov (Identifiers: NCT02431234 and NCT03920683). All patients were informed about the study objectives and procedure. Participants gave their written informed consent to participate prior to inclusion.
: Not applicable.
: The authors declare that they have no competing interests.
